HEKİMLERİMİZ


Medicana Sağlık Grubu Hastaneleri, Tüm Branşlarda SGK Anlaşmalıdır.

+A A-

Prof. Dr. Çağ Çal

Ad Soyad
Çağ Çal
Unvan
Prof. Dr.
Tıbbi Birim
Üroloji
Şube
MEDICANA INTERNATIONAL İZMİR, HİZMETİNİZDE!
Telefon
0232 970 35 35
E-Posta
cag.cal@medicana.com.tr
E-RANDEVU
Mezun Olduğu Tıp Fakültesi ve Yılı
Ege Üniversitesi Tıp Fakültesi 1988
Uzmanlık Eğitimi Aldığı Yer ve Yılı
Ege Üniversitesi Tıp Fakültesi 1995
Mesleki Deneyim
Sağlık Ocağı Hekimliği
Konya Seydişehir Gevrekli Sağlık Ocağı (Mecburi Hizmet) 1988 – 1989
Uzmanlık Öğrencisi Atatürk Sağlık Sitesi Atatürk Devlet Hastanesi Üroloji Kliniği 1989 - 1991
Uzmanlık Öğrencisi Ege Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı 1991 - 1995
Gözlemci Memorial Sloan-Kettering Cancer Center, New York, ABD Eylül 1993-Ocak 1994
Uzman Dr. Ege Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı 1995 - 2000
Gözlemci Mayo Clinic Üroloji Bölümü ve Araştırma Laboratuvarı Rochester, Minnesota, ABD Ekim 1997–Ocak 1998
Uzmanlık Sonrası Araştırma Görevlisi Kaliforniya Üniversitesi, Los Angeles, Üroloji ve İmmunoloji-Moleküler Genetik Bölümleri,Los Angeles, ABD Ocak - Mayıs 2000
Yar.Doç. Dr. Ege Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı 2000 –2001
2 Doç.Dr Ege Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı 2001-2007
Profesör. Dr. Ege Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı 2007
Profesör. Dr. Dekan Yard. İzmir Ekonomi Üniversitesi Tıp Fakültesi 2012 – 2014
Tıbbi İlgi Alanları


Özellikli İşlem


Bilimsel Yayınlar

. Çağ Çal, Arzu Sayıner, Ceyhun Özyurt, İbrahim Cüreklibatır, Tijen Özakat, Zühre Badak: Ciprofloxacin treatment in chronic prostatitis. Clinical Microbiology and Infection 3: 314-316, 1997. 2. Oktay Nazlı, Çağ Çal, Mine Hekimgil, Müge Tunçyürek: Juxtadrenal Schwannoma. International Urology and Nephrology 30 25-29, 1998. 6 3. Oktay Nazlı, Çağ Çal, Ceyhun Özyurt, Gürhan Günaydın, İbrahim Cüreklibatır, Vedat Avcıeri, Özcan Erhan: Results of Extracorporeal Shock Wave Lithotripsy in the pediatric age group. European Urology 33: 333-336, 1998. 4. Çağ Çal, Derya Keskin, Vedat Avcıeri, Mustafa Delibaş, Ceyhun Özyurt, İbrahim Cüreklibatır: The effect of alkalized papaverine on papaverine induced pain. Sexual Dysfunction 1: 39-41, 1998. 5. Çağ Çal, Derya Keskin, Mustafa Delibaş, Ceyhun Özyurt, Oktay Nazlı, İbrahim Cüreklibatır: Staging errors in localized prostate cancer. Journal of the Balkan Union of Oncology 4: 431-433, 1999. 6. Çağ Çal, Derya Keskin, Mustafa Delibaş, Ceyhun Özyurt, Gürhan Günaydın, Orhan Yurtseven: Follow-up results of radical prostatectomy. Journal of the Balkan Union of Oncology 5: 63-68, 2000. 7. Çağ Çal, Rüçhan Uslu, Gürhan Günaydın, Ceyhun Özyurt, S. Bedii Omay: Doxazosin: A new cytotoxic agent for prostate cancer? Br J Urol Int 85: 672-675, 2000. 8. Refik Killi, Çağ Çal, Ali Purgaber, Orhan Yurtseven: Primary transitional cell carcinoma of the ureter: Doppler Sonographic diagnosis. Journal of Clinical Ultrasound 28: 361-4, 2000. 9. Derya Keskin, Çağ Çal, Mustafa Delibaş, Ceyhun Özyurt, Gürhan Günaydın, Oktay Nazlı, İbrahim Cüreklibatır: Intracavernosal adrenaline injection in priapism. International Journal of Impotence Research 12: 312-314, 2000. 10. Cal C, Garban H, Jazirehi A, Yeh C, Mizutani Y, Bonavida B. Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemo-immunosensitizing Activities. Curr Med Chem Anti-Canc Agents 3: 77-93, 2003. 11. Korkut M, Icoz G, Dayangac M, Akgun E, Yeniay L, Erdogan O, Cal C. Outcome analysis in patients with Fournier’ s Gangrene. Dis Colon Rectum 46: 649-52, 2003. 12. Atuğ F, Turkeri L, Atuğ O, Cal C. Detection of Helicobacter pylori in bladder biopsy specimens of patients with interstitial cystitis by polymerase chain reaction. Urol Res. 32(5):346-9, 2004. 13. Eskicorapci SY, Karabulut E, Türkeri L, Baltaci S, Cal C, Toktas G, Akpinar H, Ozer G, Sozen S, Tokuc R, Lekili M, Soylu A, Albayrak S, Sahin H, Alpar R, Ozen H. 7 Validation of 2001 Partin tables in Turkey: a multicenter study. Eur Urol. 47(2):185-9, 2005. 14. Doganavsargil B, Simsir A, Boyacioglu H, Cal C, Hekimgil M. A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma. BJU Int. 97(3):644-8, 2006. 15. Turna B, Nazli O, Demiryoguran S, Mammadov R, Cal C. Percutaneous nephrolithotomy: variables that influence hemorrhage. Urology. 69(4):603-7, 2007 16. Adsan O, Baltaci S, Cal C, Büyükalpelli R, Uğurlu O, Bozlu M, Türkölmez K, Sahin H, Elhan A. Reliability of frozen section examination of external iliac, hypogastric, and obturator lymph nodes during radical cystectomy: a multicenter study.Urology. 69(1): 83-6, 2007. 17. Ceber E, Cakir D, Ogce F, Simsir A, Cal C, Ozentürk G. Why do men refuse prostate cancer screening? Demographic analysis in Turkey. Asian Pac J Cancer Prev. 9 (3): 387-90, 2008. 18. Asbagh LA, Uzunoglu S, Cal C. Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines. Int Braz J Urol. 34(3): 355-63, 2008. 19. Eskicorapci SY, Türkeri L, Karabulut E, Cal C, Akpinar H, Baltaci S, Baykal K; Turkish Validation Study Group of Kattan Preoperative Nomogram, Kattan MW, Ozen H.Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Urooncology Society. Urology. 74(6):1289-95, 2009. 20. Eser S, Zorlu F, Divtik RT, Cal C, Ozkan M, Kirkali Z. Incidence and epidemiological features of cancers of the genitourinary tract in Izmir between 1993-2002. Asian Pac J Cancer Prev. 10(3):491-6, 2009. 21. Simsir A, Kismali E, Mammadov R, Gunaydin G, Cal C. Is it possible to predict sepsis, the most serious complication in prostate biopsy? Urol Int. 84(4):395-9, 2010. 22. Çeber E, Şimşir A, Umar DÇ, Karababa AO, Günaydın G, Çal Ç, Özentürk G. Prevalence of prostate cancer among men aged 40+ living in Osman Gazi health care district. Asian Pac J Cancer Prev. 11(2): 473-8, 2010. 23. Türkeri L, Tanıdır Y, Çal Ç, Özen H, Şahin H; Turkish Urooncology Society. Comparison of the efficacy of single or double intravesical epirubicin instillation in the 8 early postoperative period to prevent recurrences in non-muscle-invasive urothelial carcinoma of the bladder: prospective, randomized multicenter study. Urol Int. 85(3): 261-5, 2010. 24. Simsir A, Cal C, Mammadov R, Cureklıbatir I, Semerci B, Gunaydin G. Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame? Int Braz J Urol. 37(3):328-34, 2011. 25. Aslan G, Baltaci S, Cal C, Turkeri L, Gunlusoy B, Adsan O, Sanli O, Tansug Z, Horasanli K, Uygur C, Ozen H. Bowel preparation and peri-operative management for radical cystectomy in Turkey: Turkish Urooncology Association multicenter survey. Urol J. 8(2):113-9, 2011. 26. Simsir A, Sarsik B, Cureklibatir I, Sen S, Gunaydin G, Cal C. Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status. Int Urol Nephrol. 43(4):1039-45, 2011. 27. Divrik RT, Türkeri L, Şahin AF, Akdoğan B, Ateş F, Çal Ç, Baltacı S; Urooncology Association. Prediction of response to androgen deprivation therapy and castration resistance in primary metastatic prostate cancer.Urol Int. 88(1):25-33, 2012. 28. Acar C, Cal C. Impact of Residual Fragments following Endourological Treatments in Renal Stones. Adv Urol. 2012:813523, 2012. 29. Kuzgunbay B, Yaycioglu O, Soyupak B, Kayis AA, Ayan S, Yavascaoglu I, Cal C, Beduk Y; Turkish Study Group of Public Awareness in Testicular Cancer. Public awareness of testicular cancer and self-examination in Turkey: a multicenter study of Turkish Urooncology Society. Urol Oncol. 31(3):386-91, 2013. 30. Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, Turkeri L, Yazici S, Ozen H; Society of Urooncology Study Group for Kidney Cancer Prognosis. A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer. Jpn J Clin Oncol. 43(1):63-8, 2013. 31. Aslan G, Baltaci S, Akdogan B, Kuyumcuoğlu U, Kaplan M, Cal C, Adsan O, Turkolmez K, Ugurlu O, Ekici S, Faydaci G, Mammadov E, Turkeri L, Ozen H, Beduk Y. A prospective randomized multicenter study of Turkish Society of Urooncology comparing two different mechanical bowel preparation methods for radical cystectomy. Urol Oncol. 31(5):664-70, 2013. 9 32. Soner BC, Aktug H, Acikgoz E, Duzagac F, Guven U, Ayla S, Cal C, Oktem G. Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol. Int J Mol Med. 34(5):1249-56, 2014. 33. Ugurlu O, Baltaci S, Aslan G, Can C, Cal C, Elhan A, Turkeri L, Mungan A. Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer? Korean J Urol. 56(5):35764, 2015. 34. Sarsik B, Doganavsargil B, Simsir A, Yazici A, Pehlivanoglu B, Cal C, Sen S. Pathol Oncol Res. 22(4):839-45, 2016. 35. Kizilay F, Simsir A, Cureklibatir I, Cal C. Long-Term Outcomes of Patients Who Underwent Ureterocutaneostomy. Bulletin of Urooncology 17 (2): 54-58, 2018. 36. Yuce Z, Cal C.Cancer Stem Cells in Urooncology. Crit Rev Oncog. 24(1):89-98, 2019. 37. Kizilay F, Simsir A, Akincioglu E, Kalemci S, Sen S, Sarsik B, Cal C, Cureklibatir I Analysis of Prognostic Factors Affecting Cancer-specific Survival in Renal Tumors Larger than Ten Centimeters Bulletin of Urooncology 18 (3): 99-106, 2019 38. Kizilay F, Kalemci S, Simsir A, Andabil HJ, Sarsik B, Sen S, Cal C, Cureklibatir I. Long-term Results of Patients with Testicular Tumors Undergoing Testis Sparing Surgery: A Single-center Experience. Journal of Urological Surgery 6 (2): 93-99, 2019. 39. Chi KN, Agarwal N, Bjartell A, Chung BH, et al. TITAN Investigators. Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer. N Engl J Med. 381(1):13-24, 2019

Medicana International İzmir

Adres:

Yenişehir, İşçiler Cd. No:126, 35170 Konak/İzmir

Telefon: 0 232 970 35 35
Çağrı Merkezi: 0850 460 6334